Health

FDA Moves to Pull Controversial Preterm Birth Drug From the Market

Oct 15, 2022

(MedPage Today) — The FDA is calling for withdrawal of the approval for the injectable agent 17α-hydroxyprogesterone caproate (17-OHPC; Makena) for pregnant women with a history of at least one spontaneous preterm birth, stating that the…

Related Post

Health

Georgia House health chair pushes for insuring earlier cancer screening, biomarker testing

Feb 14, 2023
Health

Bad oral hygiene could lead to ‘black hairy tongue’ – expert shares how to avoid

Feb 1, 2023
Health

Hong Kong bans CBD, forcing businesses to shut or revamp

Feb 1, 2023
Tailchaser is a division of Nella Cosa Corporation, formerly Airtime Corporation, founded in 1996. Nella Cosa Corporation has subsidiaries across different platforms, offering premium products and excellent customer service to various customer segments.